Blood Cells Molecules and Diseases

Papers
(The H4-Index of Blood Cells Molecules and Diseases is 14. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Increased expression of CD8 marker on T-cells in COVID-19 patients109
Leukocyte adhesion to P-selectin and the inhibitory role of Crizanlizumab in sickle cell disease: A standardized microfluidic assessment35
Effect of age, comorbidity and remission status on outcome of COVID-19 in patients with hematological malignancies30
Direct and indirect effects of the SARS-CoV-2 pandemic on Gaucher Disease patients in Spain: Time to reconsider home-based therapies?24
Effectiveness of convalescent plasma in Indian patients with COVID-1924
ABO blood groups, COVID-19 infection and mortality23
Hematologically important mutations: The autosomal forms of chronic granulomatous disease (third update)22
Down-regulation of lncRNA NEAT1 regulated by miR-194-5p/DNMT3A facilitates acute myeloid leukemia20
Hematologically important mutations: X-linked chronic granulomatous disease (fourth update)20
Splenectomy and the incidence of venous thromboembolism and sepsis in patients with autoimmune hemolytic anemia18
Circ-PTK2 promotes the proliferation and suppressed the apoptosis of acute myeloid leukemia cells through targeting miR-330-5p/FOXM1 axis18
Facing COVID-19 in the hematopoietic cell transplant setting: A new challenge for transplantation physicians16
Is the erythropoietin-erythroferrone-hepcidin axis intact in human neonates?15
Potential causal role of l-glutamine in sickle cell disease painful crises: A Mendelian randomization analysis14
A case of VEXAS syndrome associated with EBV-associated hemophagocytic lymphohistiocytosis14
0.090619802474976